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Summary
The transient and localized signaling events between invasive breast cancer cells and the underlying endothelial cells have remained
poorly characterized. We report a novel approach integrating vascular engineering with three-dimensional time-lapse fluorescence
resonance energy transfer (FRET) imaging to dissect how endothelial myosin light chain kinase (MLCK) is modulated during tumor
intravasation. We show that tumor transendothelial migration occurs via both paracellular (i.e. through cell-cell junctions) and transcellular
(i.e. through individual endothelial cells) routes. Endothelial MLCK is activated at the invasion site, leading to regional diphosphorylation
of myosin-II regulatory light chain (RLC) and myosin contraction. Blocking endothelial RLC diphosphorylation blunts tumor transcellular,
but not paracellular, invasion. Our results implicate an important role for endothelial myosin-II function in tumor intravasation.
Key words: FRET imaging, Cytoskeletal signaling, Endothelium, Transcellular invasion, Tumor intravasation, Vascular engineering

Introduction
The endothelial barrier presents a key rate-limiting step against
invasive tumor cells during metastasis (Zijlstra et al., 2008). Once
that barrier is breached, the tumor cells will enter the blood stream,
through which they are rapidly dispersed to distant sites where they
can colonize and establish secondary tumors. The endothelium has
been conventionally considered as an important line of defense
against tumor dissemination, in that the endothelial barrier greatly
reduces invasion rate (Wittchen et al., 2005). Several recent
findings, however, have established a novel paradigm in which
endothelial cells play significant roles in the invasiveness of cancer
cells. First, breast cancer cells exhibit increased rate of dispersion
and clearance through hematogeneous dissemination the closer they
are located to a blood vessel (Kedrin et al., 2008). Second, the
invasive potentials of several cancer cell lines have been shown to
be endothelial-cell-dependent (Mierke et al., 2008b). Although the
process of tumor invasion has been the subject of intense
investigation, the actual molecular mechanisms of tumor
transendothelial migration remain poorly understood.
The physical process of tumor intravasation involves the
interaction of at least two cell types: the invading tumor and the
opposing endothelial cell, and will engage the mechano- and
chemico-transduction properties of the cytoskeleton of the two
adjacent cells. To decipher the highly transient and localized tumormediated signals in the endothelial cells, we have devised a threedimensional (3D) assay with which we can examine the real-time
intra-endothelial signaling events, as modulated by the invading
tumor cell. This highly adaptive assay involves the engineering of

vasculature network in a 3D collagen matrix using endothelial cells
that express a fluorescent resonant energy transfer (FRET)-based
biosensor that will report the activity of myosin light chain kinase
(MLCK) in the cell in real-time (Chew et al., 2002). We could
demonstrate that the endothelial cells retain their ability to perform
mechano-sensing in the collagen matrix. More importantly, the 3D
collagen matrix environment induced extensive lumen formation,
as confirmed by confocal and electron microscopy. The endothelial
cells also showed basal-apical polarity in the correct orientation, as
characterized by deposition of 4 laminin.
Using the 3D FRET-based invasion assay, we have characterized
how the invading tumor modulates the MLCK-mediated actomyosin
function in the underlying endothelium. We show that tumor cells
are capable of transmigrating via either transcellular (i.e. through
individual cells) or paracellular (i.e. though cell-cell junctions)
routes. During transcellular invasion, the invading tumor cell
triggers MLCK activation in the endothelial cell. This MLCK
activity correlates with increased regional phosphorylation of
myosin-II regulatory light chain (RLC) and localized endothelial
myosin contraction. Using endothelial cells expressing RLC mutant
that cannot be phosphorylated, we demonstrated that MLCKmediated endothelial contractility played a key determining role in
the mechanism of tumor intravasation.
The FRET-based tumor invasion assay provides an environment
for endothelial cells to form vasculature wherein force generation can
take place in 3D physiological milieu. Using this novel assay, we
have shown that: (1) invading tumor cells, much like leukocytes, are
capable of undergoing transcellular migration; (2) tumor cells induce
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transient and regional MLCK activation and myosin contraction at
the site of invasion; and (3) the transcellular invasion route is
dependent on phosphorylation of myosin-II RLC. These results
highlight the active role of endothelial cells in tumor intravasation.
Results

Journal of Cell Science

Engineering an in vitro 3D vascular network

Endothelial cells are sensitive mechanosensors whose biological
responses include detecting and modulating subtle hemodynamic
changes as well as isometric tension. To create a platform with
which we could study the endothelial intracellular signaling
during tumor invasion, we sought to generate a vascular network
that better mimicked the physiological condition wherein
endothelial cells were exposed to 3D extracellular matrix
architecture and thus 3D isometric tension. Supplementary
material Fig. S1A,B shows the schematic of 3D gel assembly
suitable for live cell imaging. The endothelial cell-collagen gel
mixture was cast within a porous polyethylene ring centered on
top of a coverslip for confocal imaging. To assess the degree of
free fluid exchange in the gel, CellTrace Oregon Green, a nonspecific cell indicator dye, was added on top of the gel and the
penetration rate of the dye was monitored upward from the bottom
by confocal microscopy (supplementary material Fig. S1C). The
dye stained the endothelial vascular network to near saturation
level within 5 minutes. Further incubation to 10 minutes led to
no discernible increase in fluorescent intensity, indicating that there
was a rapid and free exchange of liquid, even at the very bottom
of the gel where all subsequent imaging experiments in this study
would be conducted.

Endothelial cells maintain their mechano-sensing
capability in the 3D collagen matrix

Endothelial cells formed an extensive 3D vascular network in our
collagen gels 24-30 hours following gel assembly (Fig. 1A,B). Calf
pulmonary artery endothelial (CPAE) cells, human umbilical vein
endothelial cells (HUVECs) and human microvessel endothelial
cells formed equally extensive network under these assay conditions
(data not shown).
To test whether endothelial cells maintained their ability to detect
mechanical force, we characterized the 3D architecture of the
vascular network under culture conditions with compromised
isometric tension or in collagen gel exposed to persistent isometric
tension. Cultured endothelial cells typically express 20-40 dynes
of constitutive tension (Goeckeler and Wysolmerski, 1995), and this
isometric tension is crucial in vascular development and maturation
(Ingber and Folkman, 1989a; Ingber and Folkman, 1989b; Korff
and Augustin, 1999). To abrogate the isometric tension detected by
the embedded endothelial cells, the freshly solidified collagen was
removed from the casting unit and suspended by its natural
buoyancy in liquid medium. As shown in Fig. 1C, the formation
of the vascular network was severely stunted in the absence of
isometric tension, suggesting that the endothelial cells in the 3D
matrix maintain their ability to respond to isometric force.
The 3D vascular network undergoes lumenization and
establishes basal-apical polarity

To determine the formation of lumenized network in the 3D
collagen gel, we performed confocal microscopy directly on the
CellTrace-Oregon-Green-labeled endothelial cells in the unfixed
Fig. 1. Polarized endothelial cells maintain their mechanosensing capability and form an interconnected and lumenized
3D vascular network in collagen gel matrix. (A)Confocal
micrographs of endothelial cells forming an extensive vascular
network 2 days after 3D gel assembly. (B)3D reconstruction of the
vascular network, tilted at an angle to highlight the multilayered
nascent vascular tubes. (C)Absence of vascular network in the 3D
gel with compromised isometric tension development. (D)Confocal
optical section through a nascent vessel 24 hours after gel assembly.
Note the number of vacuoles accumulating in the endothelial cell
(red arrows). The vacuoles are of various sizes and separated by
septum in the cytoplasm. (E)Confocal image of a vessel 2 days
after gel assembly shows vacuoles gradually coalesced to form
continuous lumen (red arrows). (F)At 3 days after gel assembly,
endothelial cells establish a mature 3D vascular network with wellformed lumen and also show extensive sprouting (white arrows).
The orthogonal view of the region indicated by the red dotted line
shows the formation of lumen, as indicated by the red arrows. This
network was constructed using endothelial cells expressing the
MLCK FRET sensor, shown here in monochrome green.
(G,H)Electron micrographs show the formation of lumen devoid of
extracellular matrix components (red arrows). Scale bars: 1m.
(I,J)Confocal micrographs showing the lateral and cross-sectional
view of a single lumen extending through multiple cells in the 3D
vascular network. Cell-cell border is marked by VE-cadherin
immunostaining. Arrow in each direction represents100m.
(K,L)Confocal 3D reconstructions showing endothelial cell (green)
and 4 laminin (red) deposited at the periphery of the vascular
system. The reconstructed image was digitally dissected to show the
lumen and the deposition of 4-laminin. (L)Enlarged crosssectional view of the engineered vessel, showing that the
endothelial cells established well-demarcated apical-basal polarity
in correct orientation.
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gel. The network consisted predominantly of individual endothelial
cells with intercellular connections, which in turn formed
continuous lumens, indicative of active vasculogenesis within the
3D matrix system. The lumenal spaces within this capillary
network were formed largely through intracellular vacuole
formation (Fig. 1D) and coalescence (Fig. 1E). Numerous reports
have implicated the formation of intracellular vacuoles, through
pinocytosis, as a mechanism for lumen formation in vitro and in
vivo during capillary maturation (Davis and Bayless, 2003; Dyson
et al., 1976; Folkman and Haudenschild, 1980; Kamei et al., 2006;
Montesano and Orci, 1988; Montesano et al., 1987; Nicosia et al.,
1982; Wolff and Bar, 1972). Mature vascular networks with
prominent lumen formed approximately 3 days after gel assembly
(Fig. 1F). The lumenal spaces were further confirmed by
transmission electron microscopy (Fig. 1G,H) to be free of
extracellular matrix components, indicative of bona fide lumen
formation. The lumens in the mature vascular network can also
span multiple endothelial cells (Fig. 1I,J), as indicated by anti-VEcadherin immunofluorescence. It is important to point out that a
mature vascular network could be generated with endothelial cells
expressing the MLCK FRET sensor (Fig. 1F, Fig. 2, see below),
indicating that the MLCK FRET biosensor did not interfere with
3D vascular network formation and maturation.
It was crucial to establish that the endothelial cells in our 3D
collagen system form apical-basal polarity. We characterized the
deposition of 4 laminin, using 2A3 anti-4-laminin antibody
(Gonzalez et al., 2002) in the 3D collagen matrix relative to the
vasculature and the lumenal space. Fig. 1K,L shows the deposition
of 4 laminin (red) on the basal side of the vessel and not in the
lumen. This result indicates that the endothelial cells successfully
establish apical-basal polarity in the correct orientation.
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of endothelial cells to undergo outgrowth, sprouting and anastomosis
(Nakatsu et al., 2003).
Breast cancer cells undergo transcellular invasion

To examine how breast cancer cells invade our 3D vascular
network, serum-starved MDA MB-231 metastatic breast cancer
cells were introduced into the gel either by co-assembly or multispot injection via Hamilton syringes. We could observe cells
invading the vascular network when the two types of cells came

Expressing the MLCK FRET sensor in the 3D vascular
network

To create a 3D invasion assay with which we could dynamically study
tumor-mediated endothelial cell signaling, we expressed in endothelial
cells a FRET-based, Ca2+-calmodulin-sensing, MLCK biosensor
(Chew et al., 2002). The Ca2+-calmodulin-dependent MLCK is a key
regulator of endothelial permeability. MLCK-mediated myosin-II
contraction has been shown to facilitate leukocyte diapedesis and
edema formation (Garcia et al., 1995; Garcia and Schaphorst, 1995;
Goeckeler and Wysolmerski, 1995; Wysolmerski and Lagunoff, 1990;
Wysolmerski and Lagunoff, 1991), thus highlighting MLCK as an
ideal candidate for this study. We have previously reported the
generation of a FRET sensor that can dynamically detect MLCK
activation (Chew et al., 2002). We have since exchanged the low
efficiency FRET pair of BFP and GFP to a more robust pair of CFP
and YFP (see Materials and Methods). To confirm the occurrence of
FRET, acceptor photobleaching was performed in BAPTA-AMtreated endothelial cells expressing the MLCK FRET sensor. The
emission spectra demonstrated that the desensitization of YFP was
accompanied by a simultaneous recovery in CFP emission intensity
(data not shown), confirming the occurrence of FRET, with an average
efficiency of 27.6%, calculated from 10 individual cells (data not
shown).
We constructed an adenovirus vector expressing the MLCK
FRET sensor, allowing us to routinely achieve >90% transfection
efficiency for the endothelial cells. As shown in Fig. 1F,
overexpression of the biosensor did not interfere with the formation
of lumenized 3D vascular network. This is also consistent with
previous finding that adenovirus infection did not perturb the ability

Fig. 2. Dynamic 3D interaction of MDA-MB231 breast cancer cells with
the vascular network in vitro. (A)Electron micrograph demonstrating the
deformation of endothelial cytoplasmic by an MDA-MB231 cell. Note that the
tumor cell entered an area next to the endothelial cell nucleus that is devoid of
endothelial cell-cell junction. Scale bar: 1m. (B)3D reconstruction of
confocal microscopy showing the engulfment of an MDA-MB231 cell (red)
by an endothelial cell (green). (C-E)Time-lapsed confocal microscopy
showing the extension of a finger-like protrusion (white arrows) from the
endothelial cell (green) towards the MDA-MB231 cell. (F-I)Time-lapsed
confocal microscopy shows that prolonged interaction with the tumor cell
(red) usually triggers active endothelial membrane protrusion and ruffling
(arrows). In this case, the endothelial cell protrusive spikes coalesced into a
cup-like, actively ruffling structure (see supplementary material Movie 1). The
indicated time points are in minutes:seconds. (J)Confocal micrographs
showing the maximal projection and orthogonal view of the endothelial
myosin network in 2D monolayer forming an invasion ring-like structure,
encapsulating the invading tumor cell. Scale bar: 5m. (K)3D reconstruction
of the same invasion ring (180 degree rotation of view from that presented in
J) showing a perfectly formed pore through which the tumor cell could gain
access to the other side of the endothelium. The cancer cell (red channel) is
digitally removed to show the invasion pore. (L)Single confocal optical plane
across an endothelial cell expressing GFP-RLC within a 3D vessel, indicating
that the invasion pores can also form in a 3D vasculature network, in this case
surrounding an mCherry-expressing MDA-MB231.
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into contact. Tumor cells frequently invaded into individual
endothelial cells, and deformed the endothelial cytoplasm in doing
so (Fig. 2A). In fact, cancer cells were often seen nearly or
completely engulfed inside the capillary lumen (Fig. 2B). Not all
interactions resulted in tumor cells initiating and completing a
fruitful invasion. Tumor cells also commonly adhered to
endothelial cells. This prolonged interaction often triggered active
endothelial membrane dynamics; we frequently observed
endothelial cells extending finger-like protrusions towards the
breast cancer cells (Fig. 2C-E). These protrusions were transient
and often underwent several rounds of extension and retraction.
In some cases, protrusions coalesced, resulting in highly active
membrane ruffles and subsequently forming cup-like structures
that would eventually engulf the MDA-MB231 cells. Fig. 2F-I
provides a time-lapse 3D documentation of this event (see also
supplementary material Movie 1). These rapid cytoskeletal and
membranous reorganizations supported our hypothesis that
endothelial cells might be involved in initiating and aiding the
process of tumor intravasation. Using GFP-tagged myosin-II RLC,
we showed that an invading tumor cell is encapsulated by a
cytoskeletal network within a single endothelial cell (Fig. 2J). The
myosin network formed a pore-like structure that allowed the
tumor cell to penetrate through the endothelial cell (Fig. 2K,
supplementary material Movie 2), providing strong evidence of
transcellular invasion. This invasion pore can also be found in the
3D vessel under tumor invasion (Fig. 2L).

activated on interaction with tumor cells, with the most pronounced
MLCK activity (FRET loss) at the site of endothelial-tumor contact
site. In blood vessels not invaded by tumor cells, FRET ratiometric
signals remained high, indicating the absence of MLCK activation.
This observation demonstrated that invading tumor cells could
locally affect the endothelial MLCK activity.

Breast cancer cells transiently activate endothelial MLCK
at tumor invasion sites

To test the involvement of endothelial MLCK in tumor invasion,
we utilized the high spatio-temporal resolution of our assay to
monitor the interaction between tumor and endothelial cells. Fig.
3A (top panels) shows the real-time endothelial MLCK activity
during invasion by two MDA MB231 breast cancer cells. The
bottom panels of Fig. 3A show the same set of 3D micrographs,
but with the cancer cells (red channel) digitally removed to
facilitate unobstructed viewing of the ratiometric representation
of MLCK activity. The invading tumor cells triggered endothelial
MLCK activation. First, there is an elevation of general MLCK
activity above baseline on contact with the invading tumor cells,
as shown by the drop in the FRET ratio. More importantly,
persistent invasion by MDA MB-231 cells triggered a regional
and marked decrease of FRET, indicating the activation of MLCK
(see supplementary material Movie 3). To highlight the MLCK
activation, we plotted the emission intensity profiles of both CFP
and YFP as a function of time along the white dotted line (Fig.
3B), spanning both entry sites of the tumor cells. The line scan
was performed over the central plane within the 3D vascular
volume. As evident from the data, there was a marked increase
in CFP emission at the sites of invasion with a concomitant drop
of YFP emission. This was a hallmark of FRET loss, indicative
of MLCK activation. The endothelial MLCK FRET profile did
not change when there was no interaction with tumor cells
(supplementary material Fig. S2).
In order to obtain a quantitative analysis of the invasion-mediated
endothelial MLCK activity, we compared the FRET ratiometric
values in blood vessels invaded by MDA-MB231 cells. Two
regions as defined in Fig. 3C were examined. This analysis allowed
us to ascertain the relative MLCK activities within the invasion
sites as compared with regions of the vasculature distal to the tumor
entry site. Our data indicated that endothelial cell MLCK was

Fig. 3. Breast cancer cells invade the vasculature and induce endothelial
MLCK activation. Endothelial cells expressing the MLCK sensor were used
to generate a vascular system capable of MLCK signaling read-out during
tumor invasion. (A)Portion of the blood vessel being simultaneously invaded
by two MDA-MB231 breast cancer cells (red cells, white arrows). Relative
MLCK activity is displayed using ratio imaging as previously described
(Chew et al., 2002). Loss of FRET during MLCK activation turns the ratio
color ‘bluer’, as indicated by the ratio bar. The bottom panels show the
identical 3D FRET ratiometric images, but with the red channel, which
represents the cancer cells, digitally removed to highlight the FRET changes in
the endothelial cell underneath. (B)Analysis of the CFP and YFP emission
spectra along the indicated dotted line. The invasion of the tumor cells into the
endothelium triggered a highly localized drop in YFP emission with a
concomitant increase in CFP emission intensity, indicating that MLCK was
activated. Indicated time points are in minutes:seconds (n12) (see
supplementary material Movie 2). (C)Left: Pre-defined regions for
quantitative analysis of invasion-mediated MLCK activation. The ‘invasion
site’ is defined as the region centered on the tumor entry site, spanning the
length of three tumor cells. A ‘distal site’ is defined as the region of the same
vessel tube at least two cell-lengths away from the invading cancer cell. Right:
21 invasion events were analyzed and the average FRET ratio changes were
plotted. Lower FRET ratio corresponds to higher MLCK activity. Vessels that
are not in contact with tumor cells serve as FRET ratio baseline. Error bars
represent s.e.m.
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Interaction with tumor cells triggers elevation of Ca2+
levels in endothelial cells

The FRET sensor reports MLCK activity by way of MLCK
colocalization with Ca2+-calmodulin. For the endothelial MLCK to
be modulated by invading breast cancer cells, the endogenous Ca2+
level within the endothelial cell must likewise be affected. This
provided an excellent basis for a stringent test using the Cameleon
calcium sensor (Miyawaki et al., 1997) to reciprocally confirm our
observation with the MLCK FRET sensor. Whereas our sensor
detects the Ca2+-calmodulin complex through the loss of FRET, the
Cameleon sensor detects Ca2+ levels through the gain of FRET. We
opted for the Cameleon sensor, rather than commercially available
Ca2+ dyes, as a means to keep the working conditions constant with
respect to the imaging technique (FRET) and the donor-acceptor
pair (CFP-YFP). Endothelial cells expressing the Cameleon sensor
were used to build a similar 3D vasculature system, and MDA MB231 cancer cells were allowed to invade the engineered vasculature.
As shown in Fig. 4, the interaction with tumor cell induced a
rapid increase in endogenous Ca2+ level within the endothelial cell.
Note that the increase in free Ca2+ within the endothelial cells
revealed a slightly different pattern than that detected by the MLCK
FRET sensor. The Cameleon sensor showed a more general
elevation of free Ca2+ throughout the endothelial cells, whereas the
MLCK FRET sensor indicated MLCK binding to Ca2+-calmodulin

Fig. 4. Cameleon biosensor indicates an increase in intracellular Ca2+ in
endothelial cells. (A)Time-lapse 3D FRET ratiometric confocal micrographs
of Cameleon sensor in an endothelial cell. The interaction with a MDAMB231 cell (red) induced a Ca2+ wave that was rapidly propagated along the
entire length of the endothelial cell. The Ca2+ wave is ~30% above baseline.
(n3 out of 3) All indicated time points are in minutes:seconds. (B)Real-time
raw intensity profiles of CFP and YFP from the Cameleon sensor along the
white dotted line over the endothelial cell in Fig. 4A. Red arrows bracket the
regions with increase FRET activity (high Ca2+ concentration). Note the
propagation of the Ca2+ front from the initial tumor interaction site.
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mainly at the site of active contraction, consistent with previous
findings that MLCK activation is localized (Chew et al., 2002). It
was not surprising that there was no complete overlap of elevation
patterns between free Ca2+ and the complex of MLCK-Ca2+calmodulin. However, the findings from both sensors were
consistent: interaction with tumor cells increased Ca2+-mediated
signals within the underlying endothelial cells.
Phosphorylated myosin-II RLC is enriched locally at the
site of MDA-MB231 transcellular invasion

MLCK is a highly specific kinase with only one known
physiological substrate (Bresnick, 1999; Kamm and Stull, 2001):
the 20 kDa RLC that regulates the actin-activated ATPase of
myosin-II. Unlike Rho kinase (ROCK), which monophosphorylates RLC at residue Ser19 (Amano et al., 1996), MLCK
is capable of diphosphorylating RLC at Ser19 and Thr18 (Stull et
al., 1990). Phosphorylation of the RLC at Ser19 potentiates myosin
ATPase 10- to 100-fold (Stull et al., 1990), whereas
diphosphorylation of RLC at Ser19 and Thr18 maximally activates

Fig. 5. Enrichment of diphosphorylated RLC at transcellular invasion site
in endothelial cells. (A)MDA-MB231 cell transiently expressing untagged
mCherry fluorescent protein. (B)Overlay of endothelial myosin network
(green) and an MDA-MB231 cell undergoing transcellular migration. Note the
myosin ring that surrounds the tumor cell. Scale bar: 10m. (C)Endothelial
myosin network as displayed by GFP-RLC. (D)Immunofluorescence with
antibody specific for the diphosphorylated (phosphorylated at Thr18 and
Ser19) form of RLC (RLC-pp). (E)The distribution of diphosphorylated RLC
was assessed by determining the ratio of phosphorylated RLC (from D) to total
myosin-II (from C), and displayed according to the ratio bar. Myosin with very
high phosphorylated RLC is indicated in red (white arrow). 26 out of 27
transcellular invasion events showed marked increase in RLC
diphosphorylation around the invasion ring. (F-J)Comparable analyses were
performed on MDA-MB231 cells undergoing paracellular invasion. A
representative invasion event is presented here. Scale bar: 20m. None of the
31 paracellular invasion events analyzed displayed myosin ring formation.
A representative paracellular invasion event is shown. These assays were
performed on a 2D surface to allow for accurate ratiometric imaging analysis.
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myosin-II. The marked in situ activation of MLCK suggests that
the endothelial myosin-II RLC might be locally targeted for
maximal phosphorylation. To test this hypothesis, we performed
immunofluorescence using antibodies specific for the
diphosphorylated form of RLC (Fig. 5D). GFP-tagged RLC served
as baseline control for myosin-II local concentration, irrespective
of phosphorylation state (Fig. 5C). MDA-MB 231 tumor cells were
transiently transfected with untagged mCherry protein to serve as
volume marker (Fig. 5A). The relative level of RLC
phosphorylation was obtained by normalizing the level of
phosphorylated RLC to total myosin-II local concentration as
previously described (Chew et al., 2002). As shown (Fig. 5E),
diphosphorylated RLC is enriched in the endothelial myosin
structure that encapsulates the invading tumor cell.
In paracellular invasion events (Fig. 5F-J), neither of the adjacent
endothelial cells that border the invading tumor form a ring-like
myosin structure. Small clusters of diphoshorylated RLC can be
observed around the invasion site (Fig. 5J), as well as cortical actin
structures. The level of diphosphorylated RLC concentration,
however, is significantly lower than that found in the transcellular
invasion ring.

MLCK activation mediates localized endothelial myosin-II
contraction at the tumor entry site

Our data suggest that invasive tumor cells might locally activate
endothelial myosin. To test this hypothesis, individual stress fiber
lengths within the endothelial cell were measured during tumor
invasion. Only stress fibers with both ends clearly discernible in
3D throughout the course of invasion were taken into consideration.
As shown in Fig. 6A, active shortening of endothelial cell stress
fibers occurred locally at the site of invasion. This localized stress
fiber contraction was consistent with MLCK activation, and
suggested an active role of endothelial cells in mediating tumor
transcellular intravasation.
In order to accurately quantify the rate of myosin contractile
activity, measurement of myosin-II sarcomeric distance was
performed (Fig. 6B). The lack of imaging resolution in thick
collagen gel precluded the possibility of performing this experiment
in 3D. We allowed tumor cells to invade into a 2D monolayer of
endothelial cells expressing GFP-tagged RLC, and the rate of
myosin contraction was measured as described (Fig. 6B,C).
Consistent with our RLC phosphorylation ratiometric studies (Fig.
5), myosin contractile activity was markedly potentiated around the

Fig. 6. Elevation of endothelial myosin-II contractile
activity at transcellular invasion site. (A)Confocal
micrograph of MDA-MB231 (red) transcellular invasion
into an endothelial cell expressing GFP-RLC. (middle
panels) Outline of the cells and five prominent endothelial
stress fibers are presented. (right panels) Myosin-II
contraction is expressed as a percentage stress-fiber
shortening as compared with the initial lengths. The color of
the % matches the color of the stress fiber outline (four of
four invasion events showed regional stress-fiber
shortening. Representative cell is shown). Indicated time
points are in minutes:seconds. (B)To obtain a quantitative
analysis of local increased rate of myosin contraction, two
distinct regions were pre-defined. The ‘invasion site’ (blue)
is defined as the region centered on the tumor entry site,
spanning the diameter of three tumor cells. A ‘distal site’
(green) is defined as the region of the same vessel tube at
least two cell-diameters away from the invading cancer cell.
To eliminate potential overlap, we avoided the region
immediately surrounding the invasion site (white). (C)High
resolution time-lapse 2D spinning disk confocal
micrographs showing how sarcomeric distance as indicated
by GFP-RLC can be measured. Time is in minutes:seconds.
Scale bar: 2m. Red and green arrows denotes two separate
sets of sarcomeres being measured. The actual invasion ring
usually contains myosin sarcomeres too compact to be
included for accurate measurement. (D)Rate of myosin
contraction as determined by the shortening of intersarcomeric distance (% shortening in 5 minutes) during
transcellular and paracellular invasion. Results from eight
transcellular (Trans) and eight paracellular (Para) events are
plotted (total number of sarcomeres measured was 126).
Error bars represent s.e.m.

Endothelial myosin in tumor invasion
transcellular invasion ring and, to a much lesser extent, in
paracellular invasion sites (Fig. 6D).
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RLC phosphorylation affects the tumor invasion route

Data presented thus far demonstrate that tumor cells undergoing
transcellular invasion cause activation of MLCK-mediated
endothelial myosin. To test the role of RLC phosphorylation in
determining the intravasation route, we overexpressed GFP-tagged
non-phosphorylatable RLC (Ala substitution of Thr18 and Ser19,
hereafter referred to as 18A19A RLC) mutant in endothelial cells.
The expression of 18A19A mutant did not affect the integrity of
the endothelial cell borders (supplementary material Fig. S3). In
order to obtain a high number of tumor invasion events for
statistical analyses, we adapted the assay previously used for
studying leukocyte transendothelial diapedesis (Carman and
Springer, 2004). Taking advantage of the powerful tissue cytometry
capability of the TissueGnostics system, we devised an unbiased,
sequential gating strategy to rapidly screen large population of cells
(described in Materials and Methods). This technique allowed us
to score a large number of invasion events for comparing
transcellular and paracellular routes.
MDA MB-231 cells underwent paracellular (44%) and
transcellular (56%) invasion through endothelial cells expressing
wild-type RLC (Fig. 7). However, when challenged with endothelial
cells overexpressing 18A19A RLC, tumor cells overwhelmingly
bypassed transcellular invasion (21%) and transmigrated via the
paracellular route (79%). This result implicated the direct
involvement of endothelial contractile function in mediating the
tumor intravasation.
Discussion
Engineering a lumenized 3D vascular network with
dynamic FRET read-out capability

The interaction between tumor and endothelial cells during
intravasation has hitherto been poorly characterized for several
reasons. First, transendothelial migration is transient and localized,
posing a huge challenge to any effort to study this momentary
occurrence. In addition, both cancer and endothelial cells can elicit
distinct response when cultured in a 3D environment in which
tension distribution is drastically different from that on 2D culture
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dishes (Bell et al., 2001; Darland and D’Amore, 2001; Davis et
al., 2007; Mierke et al., 2008a). Second, assays that employ
conventional 2D culture conditions, although instrumental in
identifying molecular components and signaling pathways, do not
provide accurate assessment of force generation during invasion
that takes place physiologically within dense connection tissue.
Third, most assays are directed towards the invasive potential of
the cancer cells, and consider the underlying endothelium as a
passive and permissive component in the process. Taken together,
these problems underscore the need to alter our way of studying
signal transduction during tumor intravasation. We have devised
a culture system wherein endothelial cells form a 3D vascular
network. We then integrated the resolving power of FRET into
this 3D system to dissect the MLCK activity during tumor
invasion.
Invasive mechanism of breast cancer cells in 3D milieu

The endothelial cells in our assay system did not attract the cancer
cells, and the MDA MB-231 cells did not undergo directed
chemotaxis toward the vasculature (data not shown). This
observation by no means argues against reports that implicate cancer
cell chemotaxis towards the blood vessel in vivo (Kedrin et al.,
2008). Instead, our observation is fully anticipated, as there is no
blood flow in the in vitro vascular network. The cancer cells are
not migrating directionally towards the source of any hematogenous
growth factor. However, upon random cell-cell interaction, MDAMB231 cells would invade into the 3D vascular network. We
routinely observed the cancer cells undergoing intravasation through
both transcellular and paracellular routes. Transcellular migration
is a common mechanism in leukocyte diapedesis (Carman and
Springer, 2004; Millan et al., 2006; Nieminen et al., 2006),
highlighting the intrinsic ability of endothelial cells to facilitate this
mode of entry. This notion is supported by the finding that the rate
of leukocyte transcellular diapedesis is dependent on the lineage of
the underlying endothelial cells (Carman and Springer, 2004),
implicating intra-endothelial signals in determination of the route
of intravasation. Data presented here provide evidence that the
invading tumor cells can also be involved in intra-endothelial
signaling in order to provide a mechanism for entry into the
bloodstream.

Fig. 7. MDA-MB231 transcellular invasion is dependent on
phosphorylation of endothelial myosin-II RLC.
(A)Orthogonal view of confocal micrograph showing example of
a paracellular invasion event; MDA-MB 231 cell (red), VEcadherin (light blue), GFP-RLC (green). (B)Confocal
micrograph showing example of how paracellular (red arrow) and
transcellular (white arrow) invasions are scored. Grey horizontal
line indicates the cross-sectional cut of which the orthogonal
view is presented in C. (C)Magnified orthogonal view showing
the location of VE-cadherin along the Z-axis, which is found near
the bottom slice of the Z-stacks (<900nm from the coverslip).
Arrows show that at this Z location, the breast cancer cell would
have penetrated the endothelial layer. Only images from this Zsection were used for image analysis. (D)Bar graphs and table
showing the actual cell count and the percentage of MDAMB231 invasion via paracellular and transcellular routes when
challenged by endothelial cells expressing wild-type or mutant
RLC. Endothelial cells mock-transfected with empty pEGFP-C1
vector serve as control.
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Invading tumors trigger activation of MLCK-mediated
endothelial myosin-II at the entry sites

We demonstrated that the MLCK-mediated myosin-II contractile
function is a component of intra-endothelial signals during tumor
invasion. The transient elevation of MLCK activity is mediated by
Ca2+-calmodulin, as reciprocally confirmed by two separate FRET
sensors. This Ca2+-dependent event correlates well with the
formation of transcellular pores in endothelial cells during leukocyte
diapedesis, which can also be abrogated by Ca2+ chelation (Carman
and Springer, 2004). Taken together, these findings implicate a
synergistic signal that might simultaneously mediate multiple
mechanisms in transcellular invasion.
We confirmed that RLC phosphorylation increased in correlation
with MLCK activity at the invasion site. Our immunofluorescence
experiments were performed with antibody specific for Ser19 and
Thr18 diphosphorylated RLC, and not Ser19 monophosphorylated
RLC. Therefore, the increase of RLC phosphorylation reported in
our ratiometric study was due to MLCK activation. We cannot rule
out the signals of Rho family GTPases in this assay, such as ROCK
(Amano et al., 1996) or p21-activated kinases (Chew et al., 1998;
Zeng et al., 2000), which monophosphorylate RLC at Ser19. Even
though these signaling pathways converge on RLC, they modulate
distinct myosin functions. ROCK activity contributes to the integrity
of stress fibers in anchored cells (Amano et al., 1997; Totsukawa et
al., 2000) and tail retraction in motile cells (Worthylake et al., 2001).
Conversely, MLCK can swiftly and maximally potentiate myosin-II
activity due to its high Vmax and cause rapid shortening of stress fibers.
We have previously shown that MLCK can be rapidly sequestered
along actively shortening stress fibers (Chew et al., 2002), suggesting
that it might work optimally at high local concentration.
We argued against the use of inhibitors such as Y27632 or ML7 to dissect these signals. Drug treatment would affect both cell
types in this co-culture system and preclude accurate data
interpretation. Instead, challenging the tumor cells with endothelial
cells expressing non-phosphorylatable RLC provides a cleaner
assessment, and our results confirm that tumor transcellular invasion
is dependent on endothelial RLC diphosphorylation.
Signaling events during transcellular invasion

The role of RLC phosphorylation in leukocyte migration across the
endothelium has been strongly supported by evidence that calyculin
treatment of endothelial cells led to accumulation of phosphorylated
RLC and significantly enhanced diapedesis (Verin et al., 1995). In
fact, adherent neutrophils have been shown to directly activate
endothelial MLCK in situ (Garcia et al., 1998; Hixenbaugh et al.,
1997). Hence, the interaction with tumor cells might directly
modulate endothelial cell cytoskeletal function, and subsequently
transendothelial migration.
It is unclear how tumor cells elevate endothelial Ca2+ levels, but
the process is probably mediated by cell-surface receptors. Tumorrelated adhesion molecules such as CD24 and 41 integrin are
known to bind to endothelial P-selectin and VCAM-1. Both Pselectin and VCAM-1 can induce an increase in endothelial Ca2+
when engaged and lead to cytoskeletal rearrangement (Lorenzon
et al., 1998), highlighting these molecules as prime candidates for
further studies.
The role of myosin-II contraction in transcellular invasion

Studies on immunologic transcellular migration offer an important
framework with which we can consider the role of the endothelial
contractility in tumor intravasation. The intermediate filament (IF)

Fig. 8. Postulated role of myosin-II contraction in tumor intravasation.
Schematic illustration of how myosin-II could contribute to the paracellular
and transcellular routes of tumor intravasation. Top: in the paracellular route,
perturbation of endothelial junctional complexes allows tumor cells to undergo
paracellular intravasation. Myosin-II contraction will probably increase gap
size and facilitate tumor cell transmigration. However, the disruption of
endothelial cell-cell junctions might be sufficient to allow the passage of
highly invasive tumors. Bottom: in the transcellular invasion model, the
endothelial intermediate filaments (green lines) might form a highly
interconnected cytoskeletal cage around the invading tumor cell, in close
resemblance to leukocyte trafficking (Nieminen et al., 2006). The highly
crosslinked cytoskeletal network provides a molecular handle with which the
active endothelial myosin-II contraction can facilitate the entrance of a tumor
cell into the endothelial lumen.

network is required in both the opposing endothelial cells and in
the migrating peripheral blood mononuclear cells to form an
anchoring structure that stabilizes the interaction (Nieminen et al.,
2006). IF networks of both endothelial cells and lymphocytes
undergo reorganization, and form a cage around the migrating cells
prior to transcellular diapedesis. IF is highly resistant to mechanical
stress and has been proposed to play a crucial role in the conveyance
of cytoskeletal crosstalk (Coulombe and Wong, 2004). The actin
filaments, microtubules and IF networks are inextricably
interconnected by molecular crosslinkers such as plectin (Wiche,
1998). Therefore, the formation of an IF cage around the migrating
cells might provide a molecular handle with which the endothelial
contractile machinery can pull the incoming cell into the lumen
(Fig. 8). Likewise, our data show that the endothelial myosin
network can indeed form a pore structure around the invading tumor
cell, and that myosin activity is potentiated at the invasion site for
rapid contraction. It is thus consistent with our observation that
abrogating the endothelial contraction severely curtailed the tumor
transcellular migration. Another aspect that should be considered
is that myosin contraction could provide mechanical resilience to
restrict the size of the invasion pore and prevent the endothelial
cells from being ripped apart.
Conclusion

This study provides new insight into how the endothelial signaling
cascades might be modulated by the invading tumor, and highlights
the importance of examining the process of tumor invasion from
an important yet hitherto under-explored perspective – that of the
underlying endothelium. The dependence of tumor invasion route
on endothelial contractility provides an important reminder that

Endothelial myosin in tumor invasion
tumor intravasation is a host-disease interaction, and that the
endothelium might serve as key determinant in tumor invasive
potential. Successful tumor invasion is the sum result of many
factors that constitute the tumor microenvironment (Condeelis and
Pollard, 2006; Kedrin et al., 2008; Li et al., 2007; Lunt et al., 2008;
Witz, 2006; Witz, 2008), which is experimentally difficult to
scrutinize. Our system offers a powerful way to reconstitute the
cellular, chemical and physical environment, one element at a time
if necessary, to dissect the tumor invasion mechanisms. Our
immediate future goal is to engineer a similar 3D vessel using
lymphatic endothelial cells, as the lymphatic system represents the
common route through which many cancers metastasize. However,
the engineered vascular network as a tumor invasion platform
underscores our ability to control the genotype of the cellular players
in the tumor microenvironment at will, allowing us to introduce
cell-type-specific gene manipulation without having to resort to drug
treatment, which invariably affects all cells in the tumor milieu.
Materials and Methods
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Constructs

The construction of the MLCK FRET biosensor was described previously (Chew et
al., 2002). We have modified this biosensor for the present study by replacing the
donor-acceptor pair of BFP-GFP with CFP-YFP. Both the CFP and YFP cDNAs were
PCR-amplified from the appropriate vectors of the ‘Living Colors’ vector series
purchased from Clontech Laboratories. The MLCK FRET sensor construct was
inserted into the Gateway pENTR-3C vector (Invitrogen) by directional cloning at
the KpnI and NotI sites, and recombined with pAd/CMV/V5-DEST expression vector
according to the Invitrogen Gateway LR recombination protocol. The adenovirus
was produced in HEK293A cells, and titered using the manufacturer’s protocol.
Cell culture and transfection

Calf pulmonary artery endothelial cells (ATCC) were cultured in DMEM (InvitrogenGibco) supplemented with 20% fetal calf serum (Hyclone), 1 mM sodium pyruvate,
1 mM glutamine, MEM non-essential amino acids, and penicillin-streptomycin,
buffered in 5% CO2 and incubated at 37°C. MDA MB-231 breast cancer cells (ATCC)
were cultured in Leibovitz-15, or L-15 medium (Invitrogen-Gibco) supplemented
with 10% fetal calf serum (Hyclone), 1 mM sodium pyruvate and penicillinstreptomycin. The cancer cells were grown in a 37°C incubator without CO2.
Engineering 3D vasculature in vitro

3D gels were assembled in 50 mm ‘FluoroDish’ with coverslip bottom from World
Precision Instruments (www.wplinc.com) as shown in supplementary material Fig.
S1A. The porous ring was cut from a long one-quarter inch polypropylene tube
(www.smallparts.com), and secured onto the dish with autoclaved vacuum grease.
Endothelial cell suspension was then mixed with 0.5 ml 2⫻ concentration collagen
gel master mix, to be co-assembled into 1 ml final volume of cell-collagen mixture.
At final concentration (1⫻), the collagen gel mix consisted of 1.2 mg/ml type I
collagen, 0.6 mg/ml Matrigel (BD Sciences), 1⫻ Hank’s balanced salt solution
(Cellgro), 3 g/ml laminin-10, buffered by 0.04% sodium bicarbonate. The pH of
the gel was adjusted to 7.4 with sodium hydroxide before cells were added. The cellcollagen mixture was allowed to solidify for 15 minutes at room temperature. 1.5 ml
EGM-2MV medium (supplied as a kit by Lonza) was then added before returning
the dish to the incubator. MDA-MB231 cells were introduced into the gel by either
co-culturing or by multi-spot injection through a Hamilton syringe.
Live cell imaging

Live cell imaging was performed on Zeiss LSM510 META laser scanning confocal
microscope or Olympus DSU spinning disc confocal as indicated. The occurrence
of FRET within the biosensor was confirmed by acceptor photobleaching in
endothelial cells treated with BAPTA-AM to chelate intracellular calcium in order
to maximize FRET. The photobleaching of YFP results in a concomitant increase in
CFP emission intensity in the event that FRET occurs. FRET efficiency (EFRET) was
calculated using the formula EFRET(I⬘–I) ⫻ 100/I⬘ where I and I⬘ are the CFP
fluorescence intensities before and after YFP photobleaching, respectively.
Dynamic 3D live cell FRET imaging was performed mainly on an Olympus DSU
spinning disk confocal microscope equipped with I⫻81 zero-drift compensation
(ZDC) device for active focal plane maintenance. The 3D matrix was kept in EGM2MV medium at 37°C and 5% CO2 by means of a Tokai Hit on-stage incubation
chamber. Automated image acquisition was driven by Slidebook software v4.2
(Intelligent Imaging Innovations, Santa Monica, CA). Time-lapse optical sectioning
was performed at 120-160 milliseconds exposure with a ~50 millisecond interval
between images without saturated pixels. To avoid any potential motion artifact, the
software was programmed to alternate the image acquisition sequence (i.e. AB, BA,
AB… instead of AB, AB, AB…). In order to correct for potential fluorescent bleed-
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through, images were initially acquired as described by the Youvan method (Youvan
et al., 1997) to correct for fluorescent crosstalk.
Ratiometric 3D FRET image display and analysis

MLCK activity was displayed as previously described (Chew et al., 2002). This
method has the advantage of displaying not only the relative MLCK activity, but also
the relative level of protein concentration. Briefly, the ratio comprises of the
numerator FFRET (YFP emission, with CFP excited) and the denominator FYFP (YFP
emission, with YFP excited). 3D ratio images were constructed using Volocity 5.0
software (Improvision) through intensity-modulated display, in which the ratio is
displayed in 16 different color hues with the lowest ratio (MLCK active) displayed
at the blue end of the ratio spectrum. Using the intensity of the denominator (which
serves as the internal control of MLCK relative concentration, irrespective of FRET),
the ratio colors were displayed in 16 different intensity levels by the intensitymodulated display (as shown in Fig. 3), allowing us to combine the simultaneous
display of MLCK activation and protein concentration profiles. To dissect the FRET
signal within the underlying endothelium during tumor invasion (Figs 3 and 4), a
line scan was performed across the central optical plane of the vessel for both the
CFP and the YFP channels. To reciprocally confirm the Ca2+-based signal triggered
by tumor cells, we utilized the Cameleon Ca2+ FRET sensor. The expression of the
sensor in mammalian cells was driven by the BacMam baculovirus delivery system
(Invitrogen). Endothelial cells were infected by the viral stock according to the
manufacturer’s protocol, and assembled into the 3D collagen gel as described in the
previous section. FRET ratiometric imaging was then performed in an identical fashion
to that described for the MLCK sensor. In the case of Cameleon, a gain in FRET
signifies an increase in Ca2+ levels.
Quantification of shortening of endothelial cell stress fibers in 3D gel

Stress fibers in endothelial cells were visualized using GFP-tagged myosin-II RLC.
Both GFP-tagged wild-type and mutant RLC were generous gifts from Rex Chisholm
(Northwestern University Feinberg School of Medicine, Chicago, IL). Myosin-II
contraction was quantified from the rate of stress fiber shortening within the 3D gel,
and was measured using ‘Filament Length’ module of the Volocity software.
Measurement of myosin contractile activity was performed using Volocity. Regions
of interest, as defined in Fig. 6B, were first cropped and imported into Volocity.
Thresholding of the monochrome images allowed us to easily identify and digitally
mask individual sarcomeric units. The rate of myosin contraction was then measured
as defined by the centroid of each sarcomere. Individual measurements were
abandoned following the fusion of two or more centroids.
Quantification of transendothelial invasion

Endothelial cells expressing the GFP-tagged wild-type or mutant RLC were plated
onto coverslips inside 35-mm tissue culture dishes. At 2 days after cells reached
confluency, MDA-MB231 cells labeled with CellTracker Red were plated on top of
the confluent endothelial monolayer and allowed to invade into the monolayer for
60 minutes. The dishes were then washed to remove any MDA-MB231 cells that
were not attached, and the specimens were fixed. The endothelial cell borders were
then stained with anti-VE cadherin antibody and visualized with Alexa-Fluor-633conjugated secondary antibody.
Confocal sections were obtained with a Zeiss LSM510 (1.0 Airy unit) from random
fields on the coverslips in a blinded experiment. Images were imported into
TissueQuest tissue cytometric software (TissueGnostics, Vienna, Austria;
www.tissuegnostics.com). Individual cells (both endothelial and breast cancer cells)
were identified by the software via DAPI staining. The populations of cancer and
endothelial cells were then plotted on a scattergram, and could be clearly delineated
by their red and green intensities, respectively. The cancer cell population was then
gated from the scattergram for further analysis, in an identical fashion to the method
used for a flow cytometer (further described in www.tissuegnostics.com). To
distinguish between paracellular and transcellular invasion, a second scattergram (red
vs. Alexa Fluor 633) was plotted. We further gated the cancer cells into two populations
by their colocalization with the Alexa-Fluor-633-stained VE cadherin. Paracellular
invasion would dictate the colocalization of the cancer cells with the endothelial VE
cadherin border (Fig. 7B). This sequential gating process by the TissueQuest software
allowed us to rapidly screen a large population of cells purely by their intensities and
colocalization profiles, without being biased by morphology.
Reagents, proteins and antibodies

Type I collagen was prepared as previously described (Choe et al., 2003; Parkhurst
and Saltzman, 1992). CellTracker Red and CellTrace Oregon Green were purchased
from Invitrogen (Eugene, OR). Goat polyclonal IgG anti-VE cadherin antibody was
purchased from Santa Cruz Biotechnology. We obtained the monoclonal antimyosin-II heavy chain antibody from Covance. Rabbit polyclonal antibody against
diphosphorylated (Thr18 and Ser19) RLC was supplied by Cell Signaling Technology
(Danvers, MA). Secondary antibodies of Alexa-Fluor-633-conjugated donkey antigoat and Alexa-Fluor-633-conjugated anti-mouse IgM were purchased from
Invitrogen. 2A3 antibody against the G domain of 4 laminin was a generous gift
from Jonathan Jones, Northwestern University Feinberg School of Medicine (Gonzalez
et al., 2002).
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